Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (471819/2013-1)
Fundação de Amparo à Pesquisa do Estado de Minas Gerais (03799-16, 00015-15)
Received: 21 November 2018
Accepted: 21 October 2019
First Online: 14 November 2019
Ethics approval and consent to participate
: This study is an integrated part of a project that was approved by the Institutional Review Board/Independent Ethics Committee of Federal University of Minas Gerais, appraisal codes ETIC 0069.0.203.000-1 and CAAE 44121315.2.0000.5149.
: Not applicable.
: Adriana Maria Kakehasi has received personal or institutional support from Abbvie, Janssen, Pfizer, Roche and UCB; has delivered speeches at scientific events sponsored by Janssen, Eli Lilly, Pfizer and UCB. Financial competing interest: none. Michael Ruberson Ribeiro da Silva has worked and Jéssica Barreto Ribeiro dos Santos works in Minas Gerais Secretary of State for Health. The other authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.